Dudediligence.

Puma Biotechnology, Inc

PBYINASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$80.5MSep ’24$59.1MDec ’24$46.0MMar ’25$52.4MJun ’25$54.5MSep ’25$75.5MDec ’25$44.8MMar ’26$56.5MJun ’26
Net income, by quarter
$20.3MSep ’24$19.3MDec ’24$3.0MMar ’25$5.9MJun ’25$8.8MSep ’25$13.4MDec ’25−$3.8MMar ’26$8.2MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$253.2M$228.0M$235.6M$230.5M$228.4M
Gross profit$189.5M$172.9M$173.0M$166.1M$170.2M
Operating income$1.3M$23.7M$32.6M$31.0M$37.3M
Net income−$29.1M$2,000$21.6M$30.3M$31.1M
Operating cash flow$20.6M−$15.8M$27.0M$38.9M$41.8M
Free cash flow$20.6M−$15.8M$26.9M$38.9M$41.7M
Cash$63.1M$76.2M$84.6M$69.2M$29.6M
Debt$97.1M$98.3M$99.7M$67.0M$22.5M
Shares outstanding41.2M46.3M47.6M49.1M50.4M